Sage Therapeutics Inc
SAGE
Market Cap$410.79M
Close$
$-6.59
200.4% downside
Current Fair Value
200.4% downsideOvervalued by 200.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $410.79 Million |
|---|---|
| Enterprise Value | $377.42 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-6.59 |
| Beta | 0.21 |
| Outstanding Shares | 61,857,573 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.15 |
|---|---|
| PEG | 2.14 |
| Price to Sales | 6.56 |
| Price to Book Ratio | 1.09 |
| Enterprise Value to Revenue | 3.55 |
| Enterprise Value to EBIT | -1.01 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sage Therapeutics Inc
CEO: Jeffrey Jonas